Sofinnova Investments’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-830,764
Closed -$18.2M 68
2023
Q3
$18.2M Sell
830,764
-1,729,974
-68% -$36.2M 1.15% 24
2023
Q2
$48.9M Buy
2,560,738
+1,729,495
+208% +$33.3M 3.21% 10
2023
Q1
$16.1M Buy
+831,243
New +$14.5M 1.03% 26
2021
Q4
Sell
-488,414
Closed -$10.3M 76
2021
Q3
$10.3M Sell
488,414
-591,267
-55% -$11M 0.61% 36
2021
Q2
$19.7M Buy
1,079,681
+240,500
+29% +$5.61M 1.13% 25
2021
Q1
$19M Buy
+839,181
New +$19M 1.14% 26
2018
Q4
Sell
-403,594
Closed -$7.15M 66
2018
Q3
$7.15M Buy
+403,594
New +$7.87M 0.64% 29

Other funds holding EXEL

Sofinnova Investments's EXEL Position: Q4 2023 in Review

Sofinnova Investments sold out of Exelixis (EXEL) in Q4 2023, closing a stake of 830,764 shares — an estimated $18.2M sold.

Sofinnova Investments first reported a position in EXEL in Q3 2018 and held it in 7 quarters. The position peaked at $48.9M in Q2 2023. 425 funds tracked by Wall St. Rank hold EXEL as of Q4 2023.

  • Sofinnova Investments reported no remaining Exelixis position as of Q4 2023 after selling out during the quarter.
  • Sofinnova Investments sold 830,764 Exelixis shares in Q4 2023, an estimated $18.2M.
  • Sofinnova Investments first reported a position in Exelixis in Q3 2018 and held it in 7 quarters.
  • Sofinnova Investments's Exelixis position peaked at $48.9M in Q2 2023.
  • 425 funds tracked by Wall St. Rank held Exelixis as of Q4 2023.

Based on Sofinnova Investments's 13F filing for Q4 2023, filed 13 Feb 2024.